Global gynecology drugs market stood at USD14139.56 million in 2021 and is forecast to grow at CAGR of 8.64% in the forecast years, 2023-2027 on account of rapidly increasing instances of gynecology cancer and other gynecology disorders. Gynecology drugs are therapeutics and biologics that are administered for the treatment of gynecology disorders and ailments to the women patient. Gynecology disorders affect the reproductive system of the females and cause infection or functional failure in the reproductive organs like the uterus, urinary bladder, urethra, ovaries, appendages, etc.

The Increasing Number of Gynecological Disorders

The rising global frequency of various gynecological diseases and disorders has greatly boosted the demand for gynecological medications. The majority of the world's population is inclined to use gynecological pharmaceuticals, resulting in potential demand opportunities for the gynecology drug industry. Cervical cancer, for example, is the fourth most prevalent malignancy among women, according to the World Health Organization. Cervical cancer was diagnosed in around 570 000 women worldwide in 2018, with approximately 311 000 women dying from the disease.

Increasing Elderly Female Population

During the projected period, the worldwide gynecological pharmaceuticals market is expected to benefit from an increase in the percentage of older females. As the population of elderly women grows, it is expected that they would face more gynecological issues. According to the World Population Prospects, as of 2021, there were approximately 9.5 percent females over the age of 60, with the majority of the female population susceptible to gynecological infections or disorders. As a result, the growing proportion of elderly women is boosting the global market for gynecological medications.


Click here to download the sample

Market Segmentation

The global gynecology drugs market is segmented by therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on therapeutics, the market is further bifurcated between hormonal therapy and non-hormonal therapy. Non-hormonal therapy is anticipated to hold the largest share of the market due to its advantages of efficient treatments. Moreover, rapid advancements in new drug development supports the segment's growth in the next five years. Hormonal therapy is also expected to hold a significant share of the market owing to the rising demand for new technologically advanced medicine, although the therapy has certain side effects such as the risk of breast cancer.

Major companies in the market are Amgen Inc., F. Hoffmann La Roche Ltd., Novartis AG, Bayer AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, AbbVie Inc., GlaxoSmithKline Plc, AstraZeneca Plc, Lupin Limited, Johnson and Johnson, Sanofi SA, Ferring Pharmaceuticals among others. The market players are actively involved in the technological advancements of the therapeutics as well as research and development of the medical devices involved in the administration of the gynecology drugs. Other strategies include partnerships among the market players.

Attribute

Details

Market size value in 2021

USD 14139.56 Million

Revenue Forecast in 2027

USD 21395.67 Million

United States Market Size Value in 2021

USD 3624.92 Million

Base Year

2021

Historical Years

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022E-2027F

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         Therapeutics

·         Indication

·         Distribution Channel

Regional Scope

North America; Asia Pacific; Europe, South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; Germany; France; United Kingdom; Italy; Spain; China; Japan; India; Australia; South Korea; South Africa; Saudi Arabia; UAE; Brazil; Argentina; Colombia

Key Companies Profiled

Amgen Inc., F. Hoffmann La Roche Ltd., Novartis AG, Bayer AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, AbbVie Inc., GlaxoSmithKline Plc, AstraZeneca Plc, Lupin Limited, Johnson and Johnson, Sanofi SA, Ferring Pharmaceuticals

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)

 

Report Scope:

In this report, global gynecology drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Gynecology Drugs Market, By Therapeutics:
    • Non-Hormonal Therapy
    • Hormonal Therapy
  • Global Gynecology Drugs Market, By Indication:
    • Contraception
    • Gynecology Infections
    • Female Infertility
    • Postmenopausal disorders
    • Polycystic Ovary Syndrome
    • Gynecology Cancers
    • Endometriosis
  • Global Gynecology Drugs Market, By Distribution Channel:
    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies
  • Global Gynecology Drugs Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global gynecology drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Voice of Customer

4.1.  Brand Awareness

4.2.  Factors Affecting Purchase Decision

4.3.  Product Preference, By Therapeutics

5.    Impact of COVID-19 on Global Gynecology Drugs Market

6.    Global Gynecology Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Therapeutics (Non-Hormonal Therapy vs Hormonal Therapy)

6.2.2.     By Indication (Contraception, Gynecology infections, Female infertility, Postmenopausal Disorders, Polycystic Ovary Syndrome, Gynecology Cancer, Endometriosis)

6.2.3.     By Distribution Channel (Retail Pharmacies, Hospital Pharmacies Online Pharmacies)

6.2.4.     By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

6.2.5.     By Company (2021)

6.3.  Product Market Map

7.    North America Gynecology Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Therapeutics

7.2.2.     By Indication

7.2.3.     By Distribution Channel

7.2.4.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Gynecology Drugs Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Therapeutics

7.3.1.2.2.             By Indication

7.3.1.2.3.             By Distribution Channel

7.3.2.     Canada Gynecology Drugs Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Therapeutics

7.3.2.2.2.             By Indication

7.3.2.2.3.             By Distribution Channel

7.3.3.     Mexico Gynecology Drugs Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Therapeutics

7.3.3.2.2.             By Indication

7.3.3.2.3.             By Distribution Channel

8.    Europe Gynecology Drugs Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Therapeutics

8.2.2.     By Indication

8.2.3.     By Distribution Channel

8.2.4.     By Country

8.3.  Europe: Country Analysis

8.3.1.     Germany Gynecology Drugs Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Therapeutics

8.3.1.2.2.             By Indication

8.3.1.2.3.             By Distribution Channel

8.3.2.     France Gynecology Drugs Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Therapeutics

8.3.2.2.2.             By Indication

8.3.2.2.3.             By Distribution Channel

8.3.3.     United Kingdom Gynecology Drugs Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Therapeutics

8.3.3.2.2.             By Indication

8.3.3.2.3.             By Distribution Channel

8.3.4.     Italy Gynecology Drugs Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Therapeutics

8.3.4.2.2.             By Indication

8.3.4.2.3.             By Distribution Channel

8.3.5.     Spain Gynecology Drugs Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Therapeutics

8.3.5.2.2.             By Indication

8.3.5.2.3.             By Distribution Channel

9.    Asia Pacific Gynecology Drugs Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Therapeutics

9.2.2.     By Indication

9.2.3.     By Distribution Channel

9.2.4.     By Country

9.3.  Asia Pacific: Country Analysis

9.3.1.     China Gynecology Drugs Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Therapeutics

9.3.1.2.2.             By Indication

9.3.1.2.3.             By Distribution Channel

9.3.2.     Japan Gynecology Drugs Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Therapeutics

9.3.2.2.2.             By Indication

9.3.2.2.3.             By Distribution Channel

9.3.3.     India Gynecology Drugs Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Therapeutics

9.3.3.2.2.             By Indication

9.3.3.2.3.             By Distribution Channel

9.3.4.     Australia Gynecology Drugs Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Therapeutics